Similar companies
Did NeuroSense Therapeutics Beat Earnings?
NeuroSense Therapeutics (NRSN) reported Q1 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — NeuroSense Therapeutics’s job postings, web traffic, and employee business outlook. See the full NRSN stock analysis or the earnings calendar for upcoming reports.
NeuroSense Therapeutics Quarterly Financial Trends
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net income | -860,000 | -2.1M | -1.8M | -2.4M | -2.4M | -3.2M | -3.2M | — |
| Net margin | — | — | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
NeuroSense Therapeutics Earnings Trend Analysis
Over the eight quarters from Q2 '24 to Q1 '26, NeuroSense Therapeutics’s quarterly revenue moved from $0 to $0.
When Is NeuroSense Therapeutics’s Next Earnings Date?
NeuroSense Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the NRSN earnings calendar.
Frequently Asked Questions: NeuroSense Therapeutics Earnings
NeuroSense Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
NeuroSense Therapeutics reported Q1 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the NRSN AI Score.
